DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Ophthotech (NASDAQ: OPHT)

67.69 0.50 (0.74%)

Quote as of

company name or ticker

Recent Quotes

OPHT $67.69 0.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.34
Previous Close $67.19
Daily Range $66.82 - $69.29
52-Week Range $35.38 - $72.51
Market Cap $2.3B
P/E Ratio -31.69
Dividend (Yield) $0.00 (0.0%)
Volume 219,342
Average Daily Volume 459,698
Current FY EPS -$2.89



Ophthotech (OPHT) Description

Ophthotech Corp is a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye with a focus on developing therapeutics for age-related macular degeneration. Website:

News & Commentary

3 Tiny Stocks to Buy If Biotech Tumbles

Ophthotech Corp., Portola Pharmaceuticals, and Amicus Therapeutics could be buys if biotech stocks fall.

Will Ophthotech (OPHT) Continue to Surge Higher? - Tale of the Tape

Ophthotech (OPHT) is Overbought: Is A Drop Coming? - Tale of the Tape

5 Drugs That Investors May Be Undervaluing

One Foolish investor thinks these five drugs could send shares in these companies higher.

Cowen & Company Initiates Ophthotech With Outperform

Pop! 3 To Buy If Biotech Stocks Burst

Biotech stocks are falling slightly from their lofty levels, and that may create some interesting opportunities to buy.

Commit To Buy Ophthotech Corp At $40, Earn 8.1% Annualized Using Options

Ophthotech's (OPHT) CEO David Guyer on Q1 2015 Results - Earnings Call Transcript

Will AVEO Pharmaceuticals (AVEO) Surprise This Earnings? - Analyst Blog

AVEO Upgraded to Strong Buy, Add to Your Portfolio - Analyst Blog

See More OPHT News...